Next Science Share Price and Company Fundamentals
Last traded: Today at 6:10 AM
Next Science Limited, a medical technology company, researches, develops, and commercializes technologies to eradicate issues in human health caused by biofilms. The company develops its products using its Xbio Technology platform. It offers SURGX, an antimicrobial gel designed to reduce surgical site and post-surgical infections; and BACTISURE, a surgical lavage that is used to wash out the surgery site and Intramedullary canal. The company also provides BlastX, an antimicrobial wound gel that destroys bacteria within the gel and defends from recolonization while maintaining a moist wound environment; and XPERIENCE, an no rinse antimicrobial solution that helps prevent surgical site and post-operative infections. It has strategic partnerships with Montana State University Center for Biofilm Engineering, Mayo Clinic, Texas Tech University Clinical Research Institute, Southwest Regional Wound Care Center, University of Florida Department of Otolaryngology, and Jacksonville Center for Clinical Research. Next Science Limited has operations in the United States and Australia. The company was founded in 2012 and is headquartered in Chatswood, Australia.
|Primary activities||Commercialising and developing its Xbio technology, which is a non-toxic technology with proven efficacy in eradicating both biofilm based and free-floating bacteria, in a range of products for the treatment of biofilm based infections.|
|Industry / Sector||Drug Manufacturers—Specialty & Generic / Healthcare|
|Mailing address||The Zenith Building, Tower A Suite 1902 Level 19 821 Pacific Highway Chatswood NSW 2067 Australia|
|Phone / Fax||61 2 8607 5124 /|
|Share registry||LINK MARKET SERVICES LIMITED|
Next Science does not pay dividends.
As of May 2021, following are the company executives and directors listed on Next Science.
|Ms. Judith Mitchell M.B.A.||MD, CEO & Exec. Director||276.28k|
|Dr. Matthew Myntti||Founder & CTO||350k|
|Ms. Jacqueline Butler CA (ICAEW)||Chief Financial Officer||185.88k|
|Mr. Jon Swanson||Chief Operating Officer||250k|
|Mr. Dustin Haines||Chief Commercial Officer||331.17k|
|Ms. Gillian Maria Nairn||Company Sec.|
Profitability and management effectiveness
Return on assets
Return on equity
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Next Science is 329.63M and its enterprise value is 315.09M. The enterprise value to revenue ratio of NXS is 91.57.
The NXS's stocks Beta value is 0.42 making it 58% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Next Science (NXS)
- Ansell (ANN)
- Cochlear (COH)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Healius (HLS)
- Nanosonics (NAN)
- Polynovo (PNV)
- Pro Medicus (PME)
- Ramsay Health Care (RHC)
- Resmed Inc (RMD)
- Sonic Healthcare (SHL)
Next Science (ASX:NXS) Frequently Asked Questions
1. What is Next Science's Stock Symbol?
Next Science trades on ASX under the ticker symbol "NXS".
2. What is Next Science's stock price today?
One share of NXS stock can currently be purchased for approximately $1.665.
3. How can I contact Next Science?
Next Science's mailing address is The Zenith Building, Tower A Suite 1902 Level 19 821 Pacific Highway Chatswood NSW 2067 Australia. The company can be reached via phone at 61 2 8607 5124.
4. What is Next Science's official website?
The official website of Next Science is http://www.nextscience.com.
5. Which share registry manages Next Science's stock?
Next Science's stock is managed by LINK MARKET SERVICES LIMITED.